Shares of Ironwood Pharmaceuticals (IRWD) added ~31% on Friday to hit a new 52-week high after the company set its 2026 revenue outlook ahead of Street forecasts, citing higher net sales from Linzess, ...
Ironwood Pharmaceuticals expects revenue to rise next year, boosted in part by higher sales of Linzess, its drug used to treat irritable bowel syndrome and constipation. The Boston biotechnology ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Shares of Ironwood ...
Ironwood Pharmaceuticals Inc. (NASDAQ: IRWD) stock rose Friday with a session volume of 38.35 million compared to the average volume of 2.36 million, as per data from Benzinga Pro. The ...
Yes has extended the Fragile Tour into 2026, joining former bandmates Jon Anderson and Rick Wakeman out on the concert trail. As with this year's dates in the U.S., Yes' new U.K. shows find the band ...
Add Yahoo as a preferred source to see more of our stories on Google. Former Yes frontman Jon Anderson sings in concert. We’re here to set the record straight. You haven’t seen “All Good People” until ...
We recently published 10 Small Stocks with Mighty Gains. Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) is one of the top-performing stocks on Wednesday. Ironwood Pharmaceuticals soared by 23.32 percent ...
Hosted on MSN
Ironwood Pharma’s LINZESS® Price Set by HHS
Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence. Subscribe to TipRanks' Smart Investor Picks and see our data in action through our ...
The US government said Tuesday it negotiated a 71% discount off of the list price of Novo Nordisk A/S’s blockbuster drugs Ozempic and Wegovy for Medicare patients. Medicare plans already get ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results